IQVIA Holdings Inc (IQV)
Debt-to-assets ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 12,955,000 | 12,322,000 | 12,433,000 | 11,833,000 | 12,595,000 | 12,243,000 | 12,615,000 | 12,547,000 | 12,034,000 | 12,081,000 | 12,140,000 | 12,092,000 | 12,384,000 | 12,195,000 | 11,965,000 | 11,894,000 | 11,545,000 | 11,444,000 | 11,299,000 | 11,187,000 |
Total assets | US$ in thousands | 26,681,000 | 25,977,000 | 26,036,000 | 25,739,000 | 25,337,000 | 24,223,000 | 24,413,000 | 24,969,000 | 24,689,000 | 24,033,000 | 23,937,000 | 24,467,000 | 24,564,000 | 23,837,000 | 23,183,000 | 23,078,000 | 23,251,000 | 22,892,000 | 23,068,000 | 23,109,000 |
Debt-to-assets ratio | 0.49 | 0.47 | 0.48 | 0.46 | 0.50 | 0.51 | 0.52 | 0.50 | 0.49 | 0.50 | 0.51 | 0.49 | 0.50 | 0.51 | 0.52 | 0.52 | 0.50 | 0.50 | 0.49 | 0.48 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $12,955,000K ÷ $26,681,000K
= 0.49
The debt-to-assets ratio of IQVIA Holdings Inc has remained relatively stable over the past eight quarters, ranging from 0.50 to 0.53. This ratio indicates that the company finances approximately 50-53% of its assets through debt, with the rest being funded through equity. The consistency of this ratio suggests that IQVIA has maintained a balanced capital structure, leveraging an appropriate level of debt to support its operations and investments. Overall, the trend in the debt-to-assets ratio reflects a prudent approach to managing the company's financial leverage and risk.
Peer comparison
Dec 31, 2023
Company name
Symbol
Debt-to-assets ratio
IQVIA Holdings Inc
IQV
0.49
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Charles River Laboratories
CRL
0.00
Exelixis Inc
EXEL
0.00
Incyte Corporation
INCY
0.00
Medpace Holdings Inc
MEDP
0.00